Home » Topics » Regulatory » Patents

Patents
RSS

Recent Novartis patent reports new S1P1 receptor ligands intended for transplant rejection

Dec. 1, 2008

New agents for treating neurological disorders disclosed in recent patent literature

Dec. 1, 2008

Recent AstraZeneca and Abbott patents report novel analgesic agents

Nov. 28, 2008

New antiobesity agents described in recent Schering-Plough patent

Nov. 28, 2008

Recent patents describe novel antidiabetic agents

Nov. 28, 2008

Recent GSK patents disclose novel agents for tuberculosis

Nov. 27, 2008

New immunomodulatory agents disclosed in recent Novartis patent

Nov. 27, 2008

Novel PGE2 receptor modulators emerge from Astellas R&D

Nov. 27, 2008

Novel therapeutic agents for cancer cachexia and muscle wasting imparted in recent Santhera patent

Nov. 26, 2008

Recent GSK patent claims new 5-HT1A receptor antagonists for premature ejaculation

Nov. 26, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.